Key result
Non-sedating antihistamines were associated with an increased reporting.
Why the study?
Does the systemic use of non-sedating antihistamine drugs increase the reported risk of cardiac arrhythmias compared to other drugs?
Observational
Does the systemic use of non-sedating antihistamine drugs increase the reported risk of cardiac arrhythmias compared to other drugs?
The apparent increased risk of cardiac arrhythmias with non-sedating antihistamines in spontaneous reporting systems may be largely driven by reporting bias following regulatory actions and media attention.
Answers are grounded in this paper and cite their sources.
Apparent arrhythmia signals with non-sedating antihistamines likely reflect reporting bias; leaves open any true causal risk and requires prospective confirmation.
AIMS: This study used spontaneous reports of adverse events to estimate the risk for developing cardiac arrhythmias due to the systemic use of non-sedating antihistamine drugs and compared the risk estimate before and after the regulatory action to recall the over-the-counter status of some of these drugs. METHODS: All suspected adverse drug reactions (ADRs) reported until July 1999 to the Netherlands Pharmacovigilance Foundation Lareb were used to calculate the ADR reporting odds ratio, defined as the ratio of exposure odds among reported arrhythmia cases, to the exposure odds of other ADRs (non-cases), adjusted for gender, age, reporter, year of reporting and comedication, stratified for the periods before and after the governmental decision in the Netherlands. RESULTS: Seven-hundred and thirty-seven cases of arrhythmia were reported, out of which there were 43 instances where the patients were using non-sedating antihistamines. In general non-sedating antihistamines are associated with cardiac arrhythmia to a higher extent in comparison with other drugs (ADR reporting odds ratio 2.05 [95% CI: 1.45, 2.89]). The association between arrhythmias and non-sedating antihistamine drugs calculated before 1998 was not significantly higher than 1 (OR 1.37 [95% CI: 0.85, 2.23]), whereas the risk estimate calculated after the governmental decision did significantly differ from 1 (OR 4.19 [95% CI: 2.49, 7.05]). CONCLUSIONS: Our data suggest that non-sedating antihistamines might have an increased risk for inducing arrhythmias. Our findings, however, strongly suggest that the increased risk identified can at least partly be explained by reporting bias as a result of publications about and mass media attention for antihistamine induced arrhythmias.
No takes yet. Share an insight, caveat, or question.
Bruin et al. (2002) conducted an observational in Cardiac arrhythmias. Non-sedating antihistamine drugs vs. Other drugs was evaluated on Cardiac arrhythmia (OR 2.05, 95% CI 1.45, 2.89). Non-sedating antihistamines were associated with an increased reporting.
Synapse has enriched 10 related papers. Consider them for comparative context: